Manfred Uhr

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression (2009)

Ising, Marcus, Lucae, Susanne, Binder, Elisabeth B., Bettecken, Thomas, Uhr, Manfred, Ripke, Stephan, ...

CONTEXT: The efficacy of antidepressant drug treatment in depression is unsatisfactory; 1 in 3 patients does not fully recover even after several treatment trials. Genetic factors and clinical...

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations (2006)

Then Bergh, Florian, Kümpfel, Tania, Schumann, Erina, Held, Ulrike, Schwan, Michaela, Blazevic, Mirjana, ...

Abstract Background Intravenous methylprednisolone (IV-MP) is an established treatment for multiple sclerosis (MS) relapses, accompanied by rapid, though transient reduction of gadolinium enhancing...

P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder (2006)

Lucae, Susanne, Salyakina, Daria, Barden, Nicholas, Harvey, Mario, Gagné, Bernard, Labbé, Michel, ...

The P2RX7 gene is located within a region on chromosome 12q24.31 that has been identified as a susceptibility locus for affective disorders by linkage and association studies. P2RX7 is a purinergic...

P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder (2006)

Lucae, Susanne, Salyakina, Daria, Barden, Nicholas, Harvey, Mario, Gagné, Bernard, Labbé, Michel, ...

The P2RX7 gene is located within a region on chromosome 12q24.31 that has been identified as a susceptibility locus for affective disorders by linkage and association studies. P2RX7 is a purinergic...

Einfluss des P-Glykoproteins auf die Blut-Hirn-Schrankenfunktion (2002)

Uhr, Manfred

Die vorliegende Arbeit zeigt den Einfluss und die Bedeutung des P-Glykoproteins auf die Blut-Hirn-Schrankenfunktion von zentral wirksamen Medikamenten und Steroiden. Das P-Glykoprotein ist das...

Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study

Otto, Markus, Wiltfang, Jens, Schütz, Ekkehard, Zerr, Inga, Otto, Anke, Pfahlberg, Annette, ...

Objective: To analyse serum concentrations of brain specific S100 protein in patients with Creutzfeldt-Jakob disease and in controls.

Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study

Otto, Markus, Wiltfang, Jens, Schütz, Ekkehard, Zerr, Inga, Otto, Anke, Pfahlberg, Annette, ...

Objective: To analyse serum concentrations of brain specific S100 protein in patients with Creutzfeldt-Jakob disease and in controls.